Sebaceous hyperplasia: systemic treatment with isotretinoin
An. bras. dermatol
;
90(2): 211-215, Mar-Apr/2015. tab, graf
Article
Dans Anglais
| LILACS
| ID: lil-741061
ABSTRACT
The study aimed to verify the therapeutic action of isotretinoin in the treatment of sebaceous hyperplasia. During two months, 20 patients with sebaceous hyperplasia took isotretinoin at a dosage of 1mg/kg per day. Their skin lesions were counted and photographed before and after treatment and re-evaluated two years later. The average number of sebaceous hyperplasia lesions before treatment was 24 per patient. At the end of two months of therapy, the number of lesions decreased to 2 per patient. The statistically analyzed data showed a reduction in the number of lesions following isotretinoin use (p < 0.05). Two years after the end of the treatment, the average number of sebaceous hyperplasia lesions was 4 per patient. There were no severe side effects. Thus, the data analysis suggests that isotretinoin is a safe and effective drug for treating the disease under study.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Maladies des glandes sébacées
/
Glandes sébacées
/
Isotrétinoïne
/
Produits dermatologiques
Limites du sujet:
Adulte
/
Femelle
/
Humains
langue:
Anglais
Texte intégral:
An. bras. dermatol
Thème du journal:
Dermatologie
Année:
2015
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Campinas/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS